VKTX
#1522
Viking Therapeutics, Inc. - Common Stock
33.8 6 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.51%
Changement Mensuel
+0.03%
Evolution sur 6 mois
+2.67%
Changement Annuel
+22.42%
Clôture Précédente
34.3 8
Open
33.8 6
Low
33.8 6
High
33.8 6
Volume
129
Financials
- Market Capitalization 3.95 B
- Employee 59
- Founded 2012
- CEO Brian Lian
- Website www.vikingtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG006LGV869
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1503 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 37.18 USD | +0.27% | -6.42% | +90.67% | +293.44% | 4.14 B USD | ||
| 1511 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 41.77 USD | +0.46% | +6.18% | +15.67% | +28.21% | 4.03 B USD | ||
| 1523 |  DNLI Denali Therapeutics Inc. - Common Stock | 24.67 USD | +0.41% | -2.26% | +3.31% | +52.57% | 3.94 B USD | ||
| 1533 |  RCUS Arcus Biosciences, Inc. Common Stock | 30.60 USD | -0.55% | +2.14% | +11.31% | +186.79% | 3.90 B USD |